On 2 February 2026, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (stock code: 600276) announced a share repurchase involving 465,000 A shares on the Shanghai Stock Exchange. According to the disclosure, these 465,000 shares account for approximately 0.0073% of the company’s then existing issued shares (excluding treasury shares). The highest repurchase price was RMB 57.46 and the lowest was RMB 56.37, with a total consideration of RMB 26,533,463.

Following the transaction, the number of issued shares (excluding treasury shares) stood at 6,373,908,624, while treasury shares reached 5,093,650. The total number of issued shares remained at 6,379,002,274. The repurchased shares were designated for holding as treasury shares and have not been cancelled.